FeaturesSpecial Coverage New Alzheimer’s Drug Awaits Approval, Spurs Hope May 4, 2023 Contributor Making Progress In January, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the Read More